medigraphic.com
ISSN 0210-5187 (Electronic)

2008, Number 4

<< Back Next >>

Med Cutan Iber Lat Am 2008; 36 (4)

Lip ulceration due to visceral leishmaniasis in a HIV-positive patient

Moreno-Presmanes M, Tomás-Cabedo G, Valcuende-Cavero F, Pérez Pastor G, Lázaro-Santander R

Language: Spanish
References: 13
Page: 195-198
PDF size: 201.69 Kb.


ABSTRACT

Leishmaniasis is an intracellular infection caused by the protozoa Leishmania. L. infantum may cause both cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) in Mediterranean countries.
In HIV-positive patients with VL, cutaneous lesions are sometimes the first sign of visceral involvement. We report the case of a HIV-positive patient, with a lip ulceration as a first symptom of an occult LV.


REFERENCES

  1. Alvar J, Gutiérrez-Solar B, Molina R, López-Vélez R, García Camacho A, Martínez et al. Prevalence of Leishmania infection among AIDS patients. Lancet 1992;339:1427.

  2. Choi CM, Lerner EA. Leishmaniasis as an emerging infection. J Invest Dermatol Symp Proc 2001;6:175-82.

  3. Calza L, D’Antuono A, Marinacci G, Manfredi R, Colangeli V, Passarini B et al. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS. J Am Acad Dermatol 2004;50:461-5.

  4. Dauden E, Oñate MJ. Dermatosis causadas por artrópodos, helmintos protozoos. Leishmaniasis. En: Iglesias L, Guerra A, Ortiz PL, editors. Tratado de Dermatología. Madrid: Luzan 5 SA, 1994:78-84.

  5. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996;34:257-72.

  6. Choi CM, Lerner EA. Leishmaniasis as an emerging infection. J Invest Dermatol Symp Proc 2001;6:175-82.

  7. Ara M, Maillo C, Peón G, Clavel A, Cuesta J, Grasa MP, Parapeto FJ. Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus. Br J Dermatol 1998:139:114-7.

  8. Bosch RJ, Rodrigo AB, Sánchez P, De Gálvez MV, Herrera E. Presence of leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis. Int J Dermatol 2002;41:670-5.

  9. Nva F, Sacks D. Leishmaniasis. En: Warren K, Mahmoud A, eds. Tropical and geographic medicine. 2nd ed. New York: McGraw-Hill, 1990:296:303.

  10. Cascio A, Antinori S, Campisi G, Mancuso S. Oral leishmaniasis in an HIV-infected patient. Eur J Clin Microbiol Infect Dis 2000;19:651-3.

  11. Perrin C, Taillan B, Mondain V, Lefichoux Y, Michiels JF. Atypical cutaneous histological features of visceral leishmaniasis in acquired immunodeficiency syndrome. Am J Dermatopathol 1995;17:145-50.

  12. Borgia F, Vaccaro M, Guarneri F, Manfré C, Cannavò SP, Guarneri C. Mucosal leishmaniasis occurring in a renal transplant recipient. Dermatology 2001;202:266-7.

  13. Laguna F, López-Vélez R, Pulido F, Salas A, Torre-Cisneros J, Torres E et al. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. AIDS 1999;13:1063-9.




2020     |     www.medigraphic.com